Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type, and Country | Forecast 2021-2028
As per Triton’s report, the sepsis
diagnostics market in Europe is predicted to observe growth at a CAGR of 8.36%
during the forecasting years of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this
market comprise:
• The United Kingdom
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
The market’s robust growth in
the region can be attributed to the rising prevalence of sepsis. Also, the high
mortality rate has triggered the need for early diagnosis of sepsis, which is
likely to influence the demand for sepsis diagnostics. Hence, these factors
drive the growth of the sepsis diagnostics market across Europe.
In Germany, as per multiple
surveys, there has been a gradual decline in the mortality rate associated with
sepsis. This is primarily owing to the better healthcare services provided
across the nation. Additionally, people are becoming more aware of the disease,
and healthcare professionals are becoming highly skilled. Such developments
have made the diagnosis of the disease easier and efficient. Along with this,
the country is known for its well-developed R&D infrastructure, gaining the
attention of several international companies. Hence, as stated above, these
factors support the expansion of the sepsis diagnostics market in Germany.
On the other hand, in France,
the market is majorly driven due to the surge in sepsis cases, along with the
increase in the number of diagnostic companies setting operations in the
country. As per the Pasteur Institute estimates, a non-profit dedicated to studying
diseases and vaccines, the sepsis cases are likely to double in the next 50
years due to the rise in the geriatric population. This creates a severe burden
on the healthcare industry, increasing the demand for sepsis diagnosis and
treatment, further supplementing the growth of France’s sepsis diagnostics
market.
Biomerieux SA offers solutions
and products related to the diagnosis and management of infectious diseases,
cardiovascular conditions, and targeted cancers. The company also provides
solutions for enumerating microbial flora, monitoring air and surface quality,
and sterility testing for cosmetics and other products. Its healthcare segment
serves medical clinics, pharmaceuticals, dental practitioners, and the food
manufacturing industry. Founded in 1963, the company has headquarters in France.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
SEPSIS DIAGNOSTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. CONTRACTS
AND PARTNERSHIP
2.6.2. BUSINESS
EXPANSION AND DIVESTITURES
2.6.3. ACQUISITIONS
& MERGERS
2.6.4. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS
2.7.2. INCREASED
PREVALENCE OF SEPSIS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST ASSOCIATED WITH THE INSTRUMENT
2.8.2. REIMBURSEMENT
ISSUES
2.9. MARKET
OPPORTUNITIES
2.9.1. RISING
GOVERNMENT INITIATIVES FOR RESEARCH ACTIVITIES RELATED TO SEPSIS
3. EUROPE
SEPSIS DIAGNOSTICS MARKET - BY TECHNOLOGY
3.1. MICROBIOLOGY
3.2. IMMUNOASSAY
3.3. MOLECULAR
DIAGNOSTICS
3.4. OTHER
TECHNOLOGIES
4. EUROPE
SEPSIS DIAGNOSTICS MARKET - BY DIAGNOSTIC METHOD
4.1. CONVENTIONAL
DIAGNOSTICS
4.2. AUTOMATED
DIAGNOSTICS
5. EUROPE
SEPSIS DIAGNOSTICS MARKET - BY PRODUCT
5.1. BLOOD
CULTURE MEDIA
5.2. ASSAY
KITS & REAGENTS
5.3. INSTRUMENTS
6. EUROPE
SEPSIS DIAGNOSTICS MARKET - BY PATHOGEN
6.1. GRAM
- POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS
6.2. FUNGAL
SEPSIS
6.3. OTHER
PATHOGENS
7. EUROPE
SEPSIS DIAGNOSTICS MARKET - BY TESTING TYPE
7.1. LABORATORY
TESTING
7.2. POINT-OF-CARE
TESTING
8. EUROPE
SEPSIS DIAGNOSTICS MARKET – COUNTRY OUTLOOK
8.1. COUNTRY
ANALYSIS
8.1.1. GERMANY
8.1.2. FRANCE
8.1.3. UNITED
KINGDOM
8.1.4. ITALY
8.1.5. RUSSIA
8.1.6. SPAIN
8.1.7. REST
OF EUROPE
9. COMPETITIVE
LANDSCAPE
9.1. ABBOTT
LABORATORIES
9.2. BECTON
DICKINSON AND COMPANY (CR BARD)
9.3. BIOMERIEUX
SA
9.4. BRUKER
CORPORATION
9.5. CYTOSORBENTS
9.6. DANAHER
CORPORATION
9.7. EKF
DIAGNOSTICS
9.8. F.
HOFFMANN-LA ROCHE
9.9. IMMUNEXPRESS
INC
9.10. LUMINEX
CORPORATION
9.11. RESPONSE
BIOMEDICAL CORPORATION
9.12. T2
BIOSYSTEMS INC
9.13. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5: LIST OF BUSINESS EXPANSIONS &
DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS & MERGERS
TABLE 7: LIST OF NEW PRODUCT LAUNCHES
TABLE 8: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 12: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS
TABLE 13: GRAM-POSITIVE BACTERIA CAUSING SEPSIS
TABLE 14: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: EUROPE SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 3: EUROPE SEPSIS DIAGNOSTICS
MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)
FIGURE 8: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 11: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)
FIGURE 15: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS,
2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)
FIGURE 19: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE SEPSIS
DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE SEPSIS
DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 22: GERMANY SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: FRANCE SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: UNITED KINGDOM SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: ITALY SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: RUSSIA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: SPAIN SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: REST OF EUROPE SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)